Global markets roundup, 22 August

• FTSE 100 up 0.3% to 6,778
• Gold down 1.2% to $1,276.79/oz
• £/$ – 1.6580

The FTSE 100 reversed most of Wednesday’s losses by climbing 22 points to 6,778.

Big pharma AstraZeneca led the way with a gain of 3.0%, while sector peer GlaxoSmithKline added 1.2%. And Smith & Nephew, which makes devices for the health sector, rose 1.6%.

Miners fared less well. Fresnillo finished bottom of the table, losing 3.6% and Randgold Resources fell 1.9%.

In Europe, the Paris CAC 40 rose 52 points to 4,293, and the German Xetra Dax gained 87 points to 9,402.

In the US, the Dow Jones Industrial Average gained 0.4% to 17,039, the S&P 500 added 0.3% to 1,992, the Nasdaq Composite was 0.1% higher at 4,532.

Overnight in Asia, Japan’s Nikkei 225 fell 0.3% to 15,539, and the broader Topix index lost 0.4% to 1,286. And in China, the Shanghai Composite gained 0.5% to 2,241, as did the CSI 300 to 2,365.

Brent spot was trading at $102.41 early today, and in New York, crude oil was at $93.67. Spot gold was trading at $1,279 an ounce, silver was at $19.43 and platinum was at $1,416.

In the forex markets this morning, sterling was trading against the US dollar at 1.6591 and against the euro at 1.2485. The dollar was trading at 0.7526 against the euro and 103.76 against the Japanese yen.

And in the UK, the Co-operative Bank has announced losses of £75.8m in the six months to June. While this is an improvement on the £844.6m lost during the same period in 2013, the bank admitted it lost 28,199 current account customers in the first half of this year.

• Stay up to date with MoneyWeek: Follow us on TwitterFacebook and Google+

MoneyWeek magazine

Latest issue:

Magazine cover
Faster and faster...

The frenzied pace of the high-tech revolution

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues

Which investment platform?

When it comes to buying shares and funds, there are several investment platforms and brokers to choose from. They all offer various fee structures to suit individual investing habits.
Find out which one is best for you.